Skip to main content

Table 2 How-To Guide co-production milestones

From: Co-creation of practical “how-to guides” for patient engagement in key phases of medicines development—from theory to implementation

  How-To Guide for PE
Co-production milestones Early discovery and preclinical phases (WG1) Development of a COA strategy (WG2A) Clinical trial protocol design (WG2B)
Version 1: Drafting of initial scope and structure by WG March–August 2019 June–August 2019 June–August 2019
Version 1.2: Refinement following internal WG review Shared for feedback at PE Open Forum September 2019 Shared for feedback at PE Open Forum, September 2019, and during a standalone working session held in parallel to the International Society for Pharmacoeconomics and Outcomes Research Europe, November 2019 Shared for feedback at PE Open Forum, September 2019
Version 2.0: Refinement following review and feedback January–June 2020 Shared for feedback at PE Open Forum, June 2020 January–August 2020
Shared for feedback at PE Open Forum, September 2020
October 2019–ongoing
Version 3: Refinement following internal WG and contributor network review July–November 2020 October–December 2020
Version 4: Public consultation December 2020–January 2021 Presented at Patients as Partners, January 2021 January 2021–ongoing Planned ~April/July 2021